0480-7250 : Liraglutide 6 mg/ml Subcutaneous Injection, Solution


NDC0480-7250
Labeler: Teva Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Liraglutide
Dosage Form: Subcutaneous Injection, Solution
Application #: ANDA214568
Rev. Date: 


NDC Package Codes:

  • 0480-7250-46: 5 SYRINGE, PLASTIC IN 1 CARTON (0480‑7250‑46) / 3 ML IN 1 SYRINGE, PLASTIC

Active Ingredients:

  • Liraglutide

Dosage Strength:

  • 6 mg/mL

Pharmaceutical Classes:

  • GLP-1 Receptor Agonist [EPC]
  • Glucagon-Like Peptide 1 [CS]
  • Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

Related Products:

Based on records with the same trade name.
  • 0480-3667 Liraglutide 6 mg/ml Subcutaneous Injection by Teva Pharmaceuticals USA, Inc.
  • 0143-9144 Liraglutide 6 mg/ml Subcutaneous Injection by Hikma Pharmaceuticals USA Inc.
  • 14403-3400 Liraglutide 18 mg/3ml Subcutaneous Injection, Solution by Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)
  • 50090-7501 Liraglutide 6 mg/ml Subcutaneous Injection by A-s Medication Solutions
  • 70748-346 Liraglutide 6 mg/ml Subcutaneous Injection by Lupin Pharmaceuticals, Inc.
  • 71288-563 Liraglutide 6 mg/ml Subcutaneous Injection by Meitheal Pharmaceuticals Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0480-7250 QR Code

< Prev: 0480-7168Next: 0480-7251 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.